A phase-three trial on Zepbound as a potential treatment for obstructive sleep apnea, or the pause of breathing during sleep due to blocked airways, in patients with obesity
Patients who were taking GLP-1 medications were less than half as likely to die within five years compared to those not using the drugs (15.5% versus 37.1%)
If youre considering a personalized weight loss program tailored to your unique needs, we invite you to take our free assessment quiz to determine your eligibility for prescription GLP-1 medications
No, tirzepatide is FDA-approved for subcutaneous injection only
Fatigue is one of the most common complaints
We Are Here For You Eternity Health Partners helps men and women reclaim lost energy and vigor, sharpen thinking, improve memory, decrease body fat